Cardiac Cell Generation from Encapsulated Embryonic Stem Cells in Static and Scalable Culture Systems
Open Access
- 1 November 2010
- journal article
- Published by SAGE Publications in Cell Transplantation
- Vol. 19 (11) , 1397-1412
Abstract
Heart diseases are major causes of morbidity and mortality linked to extensive loss of cardiac cells. Embryonic stem cells (ESCs) give rise to cardiomyocyte-like cells, which may be used in heart cell replacement therapies. Most cardiogenic differentiation protocols involve the culture of ESCs as embryoid bodies (EBs). Stirred-suspension bioreactor cultures of ESC aggregates may be employed for scaling up the production of cardiomyocyte progeny but the wide range of EB sizes and the unknown effects of the hydrodynamic environment on differentiating EBs are some of the major challenges in tightly controlling the differentiation outcome. Here, we explored the cardiogenic potential of mouse ESCs (mESCs) and human ESCs (hESCs) encapsulated in poly-l-lysine (pLL)-coated alginate capsules. Liquefaction of the capsule core led to the formation of single ESC aggregates within each bead and their average size depended on the concentration of seeded ESCs. Encapsulated mESCs were directed along cardiomyogenic lineages in dishes under serum-free conditions with the addition of bone morphogenetic protein 4 (BMP4). Human ESCs in pLL-layered liquid core (LC) alginate beads were also differentiated towards heart cells in serum-containing media. Besides the robust cell proliferation, higher fractions of cells expressing cardiac markers were detected in ESCs encapsulated in LC than in solid beads. Furthermore, we demonstrated for the first time that ESCs encapsulated in pLL-layered LC alginate beads can be coaxed towards heart cells in stirred-suspension bioreactors. Encapsulated ESCs yielded higher fractions of Nkx2.5- and GATA4-positive cells in the bioreactor compared to dish cultures. Differentiated cells formed beating foci that responded to chronotropic agents in an organotypic manner. Our findings warrant further development and implementation of microencapsulation technologies in conjunction with bioreactor cultivation to enable the production of stem cell-derived cardiac cells appropriate for clinical therapies and applications.Keywords
This publication has 52 references indexed in Scilit:
- Hydrodynamic modulation of embryonic stem cell differentiation by rotary orbital suspension cultureBiotechnology and Bioengineering, 2009
- Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11Proceedings of the National Academy of Sciences, 2009
- Expansion and Differentiation of Human Embryonic Stem Cells to Endoderm Progeny in a Microcarrier Stirred-Suspension CultureTissue Engineering Part A, 2009
- Characterization of embryoid bodies of mouse embryonic stem cells formed under various culture conditions and estimation of differentiation status of such bodiesJournal of Bioscience and Bioengineering, 2007
- Effect of bone morphogenetic protein-4 (BMP-4) on cardiomyocyte differentiation from mouse embryonic stem cellInternational Journal of Cardiology, 2007
- Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cellsBiomaterials, 2007
- N-cadherin is a useful marker for the progenitor of cardiomyocytes differentiated from mouse ES cells in serum-free conditionBiochemical and Biophysical Research Communications, 2006
- Alginate‐PLL microencapsulation: Effect on the differentiation of embryonic stem cells into hepatocytesBiotechnology and Bioengineering, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Paracrine promotion of cardiomyogenesis in embryoid bodies by LIF modulated endodermDifferentiation, 2001